| Translated title of the contribution | : Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System – a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC |
|---|
Klimek, L., Bärhold, F., Förster-Ruhrmann, U., Klimek, F., Rott, C., Beule, A. G., Chaker, A., Hagemann, J., Huppertz, T., Hoffmann, T. K., Dazert, S., Deitmer, T., Olze, H., Strieth, S., Wrede, H., Schlenter, W., Welkoborsky, H. J.,
Wollenberg, B., Albrecht, T. & Rudack, C.
& 11 others,
Wagenmann, M., Bergmann, C., Cuevas, M., Haxel, B., St Betz, C., Hoffmann, A. S., Beutner, C., Guntinas-Lichius, O., Laudien, M., Gröger, M. & Becker, S.,
1 Apr 2026,
In: Laryngo- Rhino- Otologie. 105,
4,
p. 210-223 14 p.Research output: Contribution to journal › Article › peer-review